Please use this identifier to cite or link to this item:
|Title:||Genetics: An 18-gene signature (ColoPrint®) for colon cancer prognosis|
|Citation:||Tan, I.B., Tan, P. (2011-03). Genetics: An 18-gene signature (ColoPrint®) for colon cancer prognosis. Nature Reviews Clinical Oncology 8 (3) : 131-133. ScholarBank@NUS Repository. https://doi.org/10.1038/nrclinonc.2010.229|
|Abstract:||coloprint® is an 18-gene expression signature designed to predict disease relapse in patients with early-stage colorectal cancer (cRc). we discuss the potential impact of coloprint® on clinical practice, and its contribution to our knowledge of cRc molecular heterogeneity. © 2011 Macmillan Publishers Limited. All rights reserved.|
|Source Title:||Nature Reviews Clinical Oncology|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jul 12, 2018
WEB OF SCIENCETM
checked on Jun 5, 2018
checked on May 18, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.